Target intelligence / Profile preview

Long intergenic non-protein coding RNA 850 (LINC00850)

Target
LINC00850
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA) [more general parent class]
01

Overview

Long intergenic non-protein coding RNA 850 (LINC00850) is a human long intergenic non-coding RNA (lincRNA) gene. LincRNAs are a subgroup of long non-coding RNAs defined by their length (>200 nucleotides) and their genomic location in regions that do not overlap any protein-coding genes. Many lincRNAs, including LINC00850, are poorly characterized and their specific molecular functions remain unknown. Generally, lincRNAs can act as regulators of gene expression, influence chromatin states, and participate in fine-tuning transcription; however, individual functions are largely gene- and context-dependent. LINC00850 is referenced in genomic studies of cancer, but there is no current evidence that it serves as a therapeutic target, interacts with drugs, or acts as a clinical biomarker.

Other names
KUCG1KUCG1 (redundant/repeat alias, sometimes listed twice in sources)LINC00850
02

Biological functions

Regulation of gene expression (epigenetic and transcriptional regulation)Potential chromatin remodeling, genome architecture adjustment, and RNA stabilization, by analogy with lincRNAs as a classFunctions may be tissue- or context-specific, but specific roles for LINC00850 are not well-established in current literature
03

Disease associations

Evidence for association with cancer and tumor genomics as it is referenced in cancer multi-platform analysis datasets, but no established direct or mechanistic link found in extracted search resultsNo direct evidence for other disease associations in current results

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 850 (LINC00850).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 850 (LINC00850).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call